Global Antisense Therapy Market Research Report 2022
SKU ID : QYR-21411221 | Publishing Date : 03-Aug-2022 | No. of pages : 90
Detailed TOC of Global Antisense Therapy Market Research Report 2022
1 Report Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antisense Therapy Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 RNA Antisense Therapy
1.2.3 DNA Antisense Therapy
1.3 Market by Application
1.3.1 Global Antisense Therapy Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Cancer
1.3.3 Cardiovascular
1.3.4 HBV
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Antisense Therapy Market Perspective (2017-2028)
2.2 Antisense Therapy Growth Trends by Region
2.2.1 Antisense Therapy Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Antisense Therapy Historic Market Size by Region (2017-2022)
2.2.3 Antisense Therapy Forecasted Market Size by Region (2023-2028)
2.3 Antisense Therapy Market Dynamics
2.3.1 Antisense Therapy Industry Trends
2.3.2 Antisense Therapy Market Drivers
2.3.3 Antisense Therapy Market Challenges
2.3.4 Antisense Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antisense Therapy Players by Revenue
3.1.1 Global Top Antisense Therapy Players by Revenue (2017-2022)
3.1.2 Global Antisense Therapy Revenue Market Share by Players (2017-2022)
3.2 Global Antisense Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Antisense Therapy Revenue
3.4 Global Antisense Therapy Market Concentration Ratio
3.4.1 Global Antisense Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antisense Therapy Revenue in 2021
3.5 Antisense Therapy Key Players Head office and Area Served
3.6 Key Players Antisense Therapy Product Solution and Service
3.7 Date of Enter into Antisense Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Antisense Therapy Breakdown Data by Type
4.1 Global Antisense Therapy Historic Market Size by Type (2017-2022)
4.2 Global Antisense Therapy Forecasted Market Size by Type (2023-2028)
5 Antisense Therapy Breakdown Data by Application
5.1 Global Antisense Therapy Historic Market Size by Application (2017-2022)
5.2 Global Antisense Therapy Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Antisense Therapy Market Size (2017-2028)
6.2 North America Antisense Therapy Market Size by Country (2017-2022)
6.3 North America Antisense Therapy Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Antisense Therapy Market Size (2017-2028)
7.2 Europe Antisense Therapy Market Size by Country (2017-2022)
7.3 Europe Antisense Therapy Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antisense Therapy Market Size (2017-2028)
8.2 Asia-Pacific Antisense Therapy Market Size by Country (2017-2022)
8.3 Asia-Pacific Antisense Therapy Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Antisense Therapy Market Size (2017-2028)
9.2 Latin America Antisense Therapy Market Size by Country (2017-2022)
9.3 Latin America Antisense Therapy Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antisense Therapy Market Size (2017-2028)
10.2 Middle East & Africa Antisense Therapy Market Size by Country (2017-2022)
10.3 Middle East & Africa Antisense Therapy Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Alnylam Pharmaceuticals
11.1.1 Alnylam Pharmaceuticals Company Detail
11.1.2 Alnylam Pharmaceuticals Business Overview
11.1.3 Alnylam Pharmaceuticals Antisense Therapy Introduction
11.1.4 Alnylam Pharmaceuticals Revenue in Antisense Therapy Business (2017-2022)
11.1.5 Alnylam Pharmaceuticals Recent Development
11.2 Ionis Pharmaceuticals, Inc.
11.2.1 Ionis Pharmaceuticals, Inc. Company Detail
11.2.2 Ionis Pharmaceuticals, Inc. Business Overview
11.2.3 Ionis Pharmaceuticals, Inc. Antisense Therapy Introduction
11.2.4 Ionis Pharmaceuticals, Inc. Revenue in Antisense Therapy Business (2017-2022)
11.2.5 Ionis Pharmaceuticals, Inc. Recent Development
11.3 Arbutus Biopharma (Tekmira)
11.3.1 Arbutus Biopharma (Tekmira) Company Detail
11.3.2 Arbutus Biopharma (Tekmira) Business Overview
11.3.3 Arbutus Biopharma (Tekmira) Antisense Therapy Introduction
11.3.4 Arbutus Biopharma (Tekmira) Revenue in Antisense Therapy Business (2017-2022)
11.3.5 Arbutus Biopharma (Tekmira) Recent Development
11.4 Isarna Therapeutics
11.4.1 Isarna Therapeutics Company Detail
11.4.2 Isarna Therapeutics Business Overview
11.4.3 Isarna Therapeutics Antisense Therapy Introduction
11.4.4 Isarna Therapeutics Revenue in Antisense Therapy Business (2017-2022)
11.4.5 Isarna Therapeutics Recent Development
11.5 Arrowhead
11.5.1 Arrowhead Company Detail
11.5.2 Arrowhead Business Overview
11.5.3 Arrowhead Antisense Therapy Introduction
11.5.4 Arrowhead Revenue in Antisense Therapy Business (2017-2022)
11.5.5 Arrowhead Recent Development
11.6 Dicerna Pharmaceuticals
11.6.1 Dicerna Pharmaceuticals Company Detail
11.6.2 Dicerna Pharmaceuticals Business Overview
11.6.3 Dicerna Pharmaceuticals Antisense Therapy Introduction
11.6.4 Dicerna Pharmaceuticals Revenue in Antisense Therapy Business (2017-2022)
11.6.5 Dicerna Pharmaceuticals Recent Development
11.7 Quark Pharmaceuticals
11.7.1 Quark Pharmaceuticals Company Detail
11.7.2 Quark Pharmaceuticals Business Overview
11.7.3 Quark Pharmaceuticals Antisense Therapy Introduction
11.7.4 Quark Pharmaceuticals Revenue in Antisense Therapy Business (2017-2022)
11.7.5 Quark Pharmaceuticals Recent Development
11.8 Benitec Biopharma
11.8.1 Benitec Biopharma Company Detail
11.8.2 Benitec Biopharma Business Overview
11.8.3 Benitec Biopharma Antisense Therapy Introduction
11.8.4 Benitec Biopharma Revenue in Antisense Therapy Business (2017-2022)
11.8.5 Benitec Biopharma Recent Development
11.9 Sylentis
11.9.1 Sylentis Company Detail
11.9.2 Sylentis Business Overview
11.9.3 Sylentis Antisense Therapy Introduction
11.9.4 Sylentis Revenue in Antisense Therapy Business (2017-2022)
11.9.5 Sylentis Recent Development
11.10 Gradalis
11.10.1 Gradalis Company Detail
11.10.2 Gradalis Business Overview
11.10.3 Gradalis Antisense Therapy Introduction
11.10.4 Gradalis Revenue in Antisense Therapy Business (2017-2022)
11.10.5 Gradalis Recent Development
11.11 Sarepta Therapeutics
11.11.1 Sarepta Therapeutics Company Detail
11.11.2 Sarepta Therapeutics Business Overview
11.11.3 Sarepta Therapeutics Antisense Therapy Introduction
11.11.4 Sarepta Therapeutics Revenue in Antisense Therapy Business (2017-2022)
11.11.5 Sarepta Therapeutics Recent Development
11.12 Biogen
11.12.1 Biogen Company Detail
11.12.2 Biogen Business Overview
11.12.3 Biogen Antisense Therapy Introduction
11.12.4 Biogen Revenue in Antisense Therapy Business (2017-2022)
11.12.5 Biogen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Figures, Tables and Charts Available in Global Antisense Therapy Market Research Report 2022
List of TablesTable 1. Global Antisense Therapy Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of RNA Antisense Therapy
Table 3. Key Players of DNA Antisense Therapy
Table 4. Global Antisense Therapy Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Antisense Therapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Antisense Therapy Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Antisense Therapy Market Share by Region (2017-2022)
Table 8. Global Antisense Therapy Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Antisense Therapy Market Share by Region (2023-2028)
Table 10. Antisense Therapy Market Trends
Table 11. Antisense Therapy Market Drivers
Table 12. Antisense Therapy Market Challenges
Table 13. Antisense Therapy Market Restraints
Table 14. Global Antisense Therapy Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Antisense Therapy Market Share by Players (2017-2022)
Table 16. Global Top Antisense Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antisense Therapy as of 2021)
Table 17. Ranking of Global Top Antisense Therapy Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Antisense Therapy Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Antisense Therapy Product Solution and Service
Table 21. Date of Enter into Antisense Therapy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Antisense Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Antisense Therapy Revenue Market Share by Type (2017-2022)
Table 25. Global Antisense Therapy Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Antisense Therapy Revenue Market Share by Type (2023-2028)
Table 27. Global Antisense Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Antisense Therapy Revenue Market Share by Application (2017-2022)
Table 29. Global Antisense Therapy Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Antisense Therapy Revenue Market Share by Application (2023-2028)
Table 31. North America Antisense Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 32. North America Antisense Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 33. Europe Antisense Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 34. Europe Antisense Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 35. Asia-Pacific Antisense Therapy Market Size by Region (2017-2022) & (US$ Million)
Table 36. Asia-Pacific Antisense Therapy Market Size by Region (2023-2028) & (US$ Million)
Table 37. Latin America Antisense Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 38. Latin America Antisense Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 39. Middle East & Africa Antisense Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 40. Middle East & Africa Antisense Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 41. Alnylam Pharmaceuticals Company Detail
Table 42. Alnylam Pharmaceuticals Business Overview
Table 43. Alnylam Pharmaceuticals Antisense Therapy Product
Table 44. Alnylam Pharmaceuticals Revenue in Antisense Therapy Business (2017-2022) & (US$ Million)
Table 45. Alnylam Pharmaceuticals Recent Development
Table 46. Ionis Pharmaceuticals, Inc. Company Detail
Table 47. Ionis Pharmaceuticals, Inc. Business Overview
Table 48. Ionis Pharmaceuticals, Inc. Antisense Therapy Product
Table 49. Ionis Pharmaceuticals, Inc. Revenue in Antisense Therapy Business (2017-2022) & (US$ Million)
Table 50. Ionis Pharmaceuticals, Inc. Recent Development
Table 51. Arbutus Biopharma (Tekmira) Company Detail
Table 52. Arbutus Biopharma (Tekmira) Business Overview
Table 53. Arbutus Biopharma (Tekmira) Antisense Therapy Product
Table 54. Arbutus Biopharma (Tekmira) Revenue in Antisense Therapy Business (2017-2022) & (US$ Million)
Table 55. Arbutus Biopharma (Tekmira) Recent Development
Table 56. Isarna Therapeutics Company Detail
Table 57. Isarna Therapeutics Business Overview
Table 58. Isarna Therapeutics Antisense Therapy Product
Table 59. Isarna Therapeutics Revenue in Antisense Therapy Business (2017-2022) & (US$ Million)
Table 60. Isarna Therapeutics Recent Development
Table 61. Arrowhead Company Detail
Table 62. Arrowhead Business Overview
Table 63. Arrowhead Antisense Therapy Product
Table 64. Arrowhead Revenue in Antisense Therapy Business (2017-2022) & (US$ Million)
Table 65. Arrowhead Recent Development
Table 66. Dicerna Pharmaceuticals Company Detail
Table 67. Dicerna Pharmaceuticals Business Overview
Table 68. Dicerna Pharmaceuticals Antisense Therapy Product
Table 69. Dicerna Pharmaceuticals Revenue in Antisense Therapy Business (2017-2022) & (US$ Million)
Table 70. Dicerna Pharmaceuticals Recent Development
Table 71. Quark Pharmaceuticals Company Detail
Table 72. Quark Pharmaceuticals Business Overview
Table 73. Quark Pharmaceuticals Antisense Therapy Product
Table 74. Quark Pharmaceuticals Revenue in Antisense Therapy Business (2017-2022) & (US$ Million)
Table 75. Quark Pharmaceuticals Recent Development
Table 76. Benitec Biopharma Company Detail
Table 77. Benitec Biopharma Business Overview
Table 78. Benitec Biopharma Antisense Therapy Product
Table 79. Benitec Biopharma Revenue in Antisense Therapy Business (2017-2022) & (US$ Million)
Table 80. Benitec Biopharma Recent Development
Table 81. Sylentis Company Detail
Table 82. Sylentis Business Overview
Table 83. Sylentis Antisense Therapy Product
Table 84. Sylentis Revenue in Antisense Therapy Business (2017-2022) & (US$ Million)
Table 85. Sylentis Recent Development
Table 86. Gradalis Company Detail
Table 87. Gradalis Business Overview
Table 88. Gradalis Antisense Therapy Product
Table 89. Gradalis Revenue in Antisense Therapy Business (2017-2022) & (US$ Million)
Table 90. Gradalis Recent Development
Table 91. Sarepta Therapeutics Company Detail
Table 92. Sarepta Therapeutics Business Overview
Table 93. Sarepta Therapeutics Antisense TherapyProduct
Table 94. Sarepta Therapeutics Revenue in Antisense Therapy Business (2017-2022) & (US$ Million)
Table 95. Sarepta Therapeutics Recent Development
Table 96. Biogen Company Detail
Table 97. Biogen Business Overview
Table 98. Biogen Antisense TherapyProduct
Table 99. Biogen Revenue in Antisense Therapy Business (2017-2022) & (US$ Million)
Table 100. Biogen Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antisense Therapy Market Share by Type: 2021 VS 2028
Figure 2. RNA Antisense Therapy Features
Figure 3. DNA Antisense Therapy Features
Figure 4. Global Antisense Therapy Market Share by Application in 2021 & 2028
Figure 5. Cancer Case Studies
Figure 6. Cardiovascular Case Studies
Figure 7. HBV Case Studies
Figure 8. Other Case Studies
Figure 9. Antisense Therapy Report Years Considered
Figure 10. Global Antisense Therapy Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global Antisense Therapy Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Antisense Therapy Market Share by Region: 2021 VS 2028
Figure 13. Global Antisense Therapy Market Share by Players in 2021
Figure 14. Global Top Antisense Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antisense Therapy as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Antisense Therapy Revenue in 2021
Figure 16. North America Antisense Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 17. North America Antisense Therapy Market Share by Country (2017-2028)
Figure 18. United States Antisense Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Canada Antisense Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Antisense Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Antisense Therapy Market Share by Country (2017-2028)
Figure 22. Germany Antisense Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. France Antisense Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. U.K. Antisense Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Italy Antisense Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Russia Antisense Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Nordic Countries Antisense Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Antisense Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Antisense Therapy Market Share by Region (2017-2028)
Figure 30. China Antisense Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Japan Antisense Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. South Korea Antisense Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Southeast Asia Antisense Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. India Antisense Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Australia Antisense Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America Antisense Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America Antisense Therapy Market Share by Country (2017-2028)
Figure 38. Mexico Antisense Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Brazil Antisense Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa Antisense Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa Antisense Therapy Market Share by Country (2017-2028)
Figure 42. Turkey Antisense Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Saudi Arabia Antisense Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Alnylam Pharmaceuticals Revenue Growth Rate in Antisense Therapy Business (2017-2022)
Figure 45. Ionis Pharmaceuticals, Inc. Revenue Growth Rate in Antisense Therapy Business (2017-2022)
Figure 46. Arbutus Biopharma (Tekmira) Revenue Growth Rate in Antisense Therapy Business (2017-2022)
Figure 47. Isarna Therapeutics Revenue Growth Rate in Antisense Therapy Business (2017-2022)
Figure 48. Arrowhead Revenue Growth Rate in Antisense Therapy Business (2017-2022)
Figure 49. Dicerna Pharmaceuticals Revenue Growth Rate in Antisense Therapy Business (2017-2022)
Figure 50. Quark Pharmaceuticals Revenue Growth Rate in Antisense Therapy Business (2017-2022)
Figure 51. Benitec Biopharma Revenue Growth Rate in Antisense Therapy Business (2017-2022)
Figure 52. Sylentis Revenue Growth Rate in Antisense Therapy Business (2017-2022)
Figure 53. Gradalis Revenue Growth Rate in Antisense Therapy Business (2017-2022)
Figure 54. Sarepta Therapeutics Revenue Growth Rate in Antisense Therapy Business (2017-2022)
Figure 55. Biogen Revenue Growth Rate in Antisense Therapy Business (2017-2022)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Keyplayers in Global Antisense Therapy Market Research Report 2022
Alnylam PharmaceuticalsIonis Pharmaceuticals, Inc.
Arbutus Biopharma (Tekmira)
Isarna Therapeutics
Arrowhead
Dicerna Pharmaceuticals
Quark Pharmaceuticals
Benitec Biopharma
Sylentis
Gradalis
Sarepta Therapeutics
Biogen